Article
Importance of familial predisposition to heart failure to the risk of anthracycline-related cardiotoxicity: A nationwide study.
American heart journal - 1 Nov 2023
Banke Ann, Andersson Charlotte, D'Souza Maria, Fosbøl Emil, Nielsen Dorte, Pedersen Christian Torp, Gislason Gunnar H, Møller Jacob Eifer, Køber Lars, Rasmussen Christian Madelaire, Schou Morten
Abstract excerpt
BACKGROUND: Anthracycline-based chemotherapy has improved the prognosis of various malignancies, but increases the long-term risk of heart failure (HF). Identification of patients at risk prior to treatment initiation is warranted. Therefore, the aim of this study was to evaluate if a familial predisposition to HF increases the risk of anthracycline related HF. METHODS: Using nationwide Danish registries, all...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
